Our OfficeHours Series is a recurring, dependable, and resilient space for connection and real-time conversations with colleagues and guests.
Whether you join us live to engage directly, send questions or comment thoughts in advance, or listen and participate asynchronously through the recorded podcast, we’re glad you’re here.
Veterinary Medical Entrepreneurship with Dr. João Gewehr
Welcome back to First Tuesday Office Hours with Dr. João Lourenço Hasckel Gewehr where we focus on the unique challenges and resiliency strategies for entrepreneurs in the veterinary medical fields and animal care industries.
Watch Dr. Gewehr’s full intro and bio in our first podcast episode here and learn about his startup - Bliss Education, Cannabis Education for Veterinarians.
Read Dr. Gewehr’s recently published paper on results from his masters thesis - Full spectrum cannabidiol-rich extract reduced propofol dosage required for anesthetic induction in dogs—a pilot study
In this May 2025 episode, we are piloting a form of community case rounds in a Think-Tank format with the goals of:
transparency in medical consultations
accessible and digestible veterinary guidance in a shifting medical landscape
community resiliency & networked ideas
In this episode, we are also thrilled to welcome our guest panelist, Dr. Stephanie Patterson, the veterinarian joining the MyosCorps team.
Dr. Patterson received her Bachelor of Arts in Biology with Specialization in Marine Science from Boston University. She then went on to earn her DVM at Tufts University School of Veterinary Medicine, followed by a rotating internship focusing on Emergency/Critical Care and Internal Medicine in the Virginia Beach area. Dr. Patterson is a Certified Veterinary Acupuncturist, a Certified Canine Rehabilitation Therapist, and a Certified Veterinary Pain Practitioner.
Recently, Dr. Patterson has joined the MyosCorps team and we’re honored to have her contribute to our discussion with expertise about the fortetropin supplement - Myos. As we discuss today’s case, the Dr. Patterson contributes her expertise on the use of the fortetropin supplement alongside cannabis in a veterinary cardiac case.
Cannabis & Fortetropin Use in a Veterinary Cardiac Case
Cannabis-derived products have demonstrated impressive safety in their clinical use in veterinary patients. With wide implementation by pet parents, with or without veterinary guidance, and a large array of potential clinical applications - familiarity with the endocannabinoid system (ECS), and the interactions that already occur with our everyday-clinical-use modalities as well as emerging medical use molecules such as cannabis-derived molecules and fortetropin, affect every patient’s case.
Knowledge of the ECS, cannabis-derived products, and emerging supplement markets are essential components of every veterinary professional’s toolkit.
About Cannabis-derived products
Cannabis-derived molecules have impressive safety profiles in veterinary patients, but cautious for their use DO exist and are important to recognize. One very frequently encountered clinical caution is for the use of cannabis in cardiac patients.
With Dr. Gewehr and Dr. Patterson, today our community discusses the clinical pros, cons, risks, and considerations of including supplements such as cannabis and fortetropin in a veterinary canine cardiac patient.
Meet Milo.
Topics and Links from this Conversation
Myos muscle formula with BCAA (product link)
Cultivate Community Class - Improving Pet Muscle Health with MyosCorp
Double muscled cattle (wikipedia reference)
Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats (link)
Comparison of Five Oral Cannabidiol Preparations in Adult Humans: Pharmacokinetics, Body Composition, and Heart Rate Variability (link)
Full spectrum cannabidiol-rich extract reduced propofol dosage required for anesthetic induction in dogs—a pilot study
Human-directed fortetropin product - Yolked.
Share this post